Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies
Abstract Background: In randomized controlled trials, add-on cannabidiol (CBD) has been shown to reduce seizure frequency in patients with Lennox-Gastaut…